TCM Biotech International Corp. (TPEX:4169)

TCM Biotech International Revenue

TCM Biotech International had revenue of 329.94M TWD in the half year ending June 30, 2024, a decrease of -11.53%. This brings the company's revenue in the last twelve months to 834.32M, down -6.75% year-over-year. In the year 2023, TCM Biotech International had annual revenue of 969.62M with 20.84% growth.

• Revenue (ttm): 834.32M
• Revenue Growth: -6.75%
• P/S Ratio: 3.69
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	969.62M	167.20M	20.84%
Dec 31, 2022	802.42M	100.38M	14.30%
Dec 31, 2021	702.05M	-35.03M	-4.75%
Dec 31, 2020	737.08M	168.45M	29.62%
Dec 31, 2019	568.63M	28.40M	5.26%